Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2007 / Cilt: 41 - Sayı: 4

Frequency of anemia of chronic disease in patients with Behcet's disease

Behçet hastalarında kronik hastalık anemisi sıklığı

Pages
121–124
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anemia was determined as hemoglobin levels

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anemia of chronic disorders is a mild to moderate anemia characterized by decreased serum iron, decreased total iron-binding capacity and increased iron stores.
📊
Key Findings & Data:Material and Method: The study included 40 patients with Behcet’s disease and 20 healthy volunteers.
💡
Conclusion & Impact:Anemia was determined as hemoglobin levels
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anemia of chronic disorders is a mild to moderate anemia characterized by decreased serum iron, decreased total iron-binding capacity and increased iron stores. Anemia of chronic disorders occurs in a wide variety of diseases including cancer, chronic infections and inflammatory disorders. Behcet’s disease is a chronic and inflammatory disease. There is a possibility of anemia of chronic disorders in Behcet’s disease. But, frequency of anemia of chronic disorders in Behcet’s disease was never evaluated in previous studies. Thus, we aimed to determine the frequency of anemia of chronic disease in Behcet’s disease. Material and Method: The study included 40 patients with Behcet’s disease and 20 healthy volunteers. Serum iron, hemoglobin, ferritin, UIBC and TIBC levels were assessed. Anemia was determined as hemoglobin levels

Özet

Kronik hastal›k anemisi (KHA); serum demir, total demir ba¤lama kapasitesinde azalma ve demir depolar›nda art›fl ile seyreden, hafif-orta fliddette bir anemi tablosudur. Kanserler, inflamatuvar hastal›klar ve kronik infeksiyonlar gibi çeflitli hastal›klarda KHA görülebilir. Kronik seyirli ve inflamatuvar bir hastal›k olan Behçet hastal›¤›nda KHA geliflmesi olas› görünmektedir. Önceki çal›flmalarda Behçet hastal›¤›nda KHA s›kl›¤› hiç de¤erlendirilmemifltir. Bu nedenle çal›flmam›zda Behçet hastalar›nda KHA’y› araflt›rmay› amaçlad›k. Gereç ve Yöntem: Çal›flmaya 40 Behçet hastas› ile 20 sa¤l›kl› gönüllü al›nd›. Hastalar›n serum demir, hemoglobin, ferritin, doymam›fl demir ba¤lama kapasitesi (unsaturated iron binding capacity (UIBC)) ve total demir ba¤lama kapasitesi (total iron binding capacity (TIBC)) de¤erleri ölçüldü. Behçet hastalar› ve kontrol grubunda erkek için

🔖

Cite This Article

ÇİÇEK, D., DEMİR, B., KANDİ, B., DERTLİOĞLU, B. S., İLHAN, N. (2022). Frequency of anemia of chronic disease in patients with Behcet's disease. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 41 - Sayı: 4, 121–124. https://ajindex.com/articles/622127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Freysdott›r J, Lav SH, Fortune F. gd T cells in Behçet’s disease and recurrent, aphthous stomatitis. Clin Exp Immunol 1999; 118: 451-7
  2. Ako¤lu T. Behçet hastal›¤› patogenezi. Aktüel T›p Dergisi 1997; 2: 80-6
  3. Izaks GJ, Westendorp RGJ, Knook DL; The definition of anemia in older persons. JAMA 1999; 281; 1714-7
  4. Richer SA. practical guide for differentiating between iron deficiency. Anemia and Anemia of Chronic Disease in Children and Adults. 1997; 22: 82-101
  5. Hansen TM, Hansen NE, Birgens HS, Holund B, Lorenzen I. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 1983; 12: 353-9
  6. Vreugdenhil G, Baltus CA, van Eijk HG, Swaak AJ. Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients. Br J Rheumatol 1990; 29: 105-10
  7. Glossop JR, Dawes PT, Hassell AB, Mattey DL. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes. J Rheumatol 2005; 32: 1673-978
  8. Weiss G, Goodnough LT. Anemia of chronic disease. NEngl J Med 2005; 352: 1011-23
  9. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003; 2: 116-21
  10. Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 2004; 116: 50-7
  11. Salvarani C, Casali B, Salvo D, et al. The role of interleukin1, erythropoietin and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis. Clin Exp Rheumatol 1991; 9: 241-6
  12. The International Study Group for Behcet's disease. Evaluation of diagnostic ('classification') criteria in Behcet's disease-towards internationally agreed criteria. Br J Rheumatol. 1992; 31: 299-308. 13. van der Meer P, Lipsic E, Henning RH, de Boer RA, Suurmeijer AJ, van Veldhuisen DJ, van Gilst WH. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 2004; 6: 853-9
  13. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with newonset heart failure. Circulation 2003; 107: 223-5
  14. Segal R, Baumoehl Y, Elkayam O, Levartovsky D, Litinsky I, Paran D, Wigler I, Habot B, Leibovitz A, Sela BA, Caspi D. Anemia, serum vitamin B12, and folic acid in patients with rheumatoi